Showing 1-11 of 11 resultados for "SRP3261"
Junlei Zhang et al.
Nature communications, 5, 5042-5042 (2014-10-07)
Nanog expression is heterogeneous and dynamic in embryonic stem cells (ESCs). However, the mechanism for stabilizing pluripotency during the transitions between Nanog(high) and Nanog(low) states is not well understood. Here we report that Dax1 acts in parallel with Nanog to...
Fibroblast growth factors.
Ornitz, D.M. and Itoh, N.
Genome Biology, 2 (3), 1-3005 (2001)
Tongtong Cui et al.
Cell reports, 26(2), 407-414 (2019-01-10)
Trophoblast stem (TS) cells are increasingly used as a model system for studying placentation and placental disorders. However, practical limitations of genetic manipulation have posed challenges for genetic analysis using TS cells. Here, we report the generation of mouse parthenogenetic haploid...
Chondrogenic induction of human mesenchymal stem cells using combined growth factors for cartilage tissue engineering.
Bosetti M, et al.
Journal of Tissue Engineering and Regenerative Medicine, 6, 205-205 (2012)
Evgeniya A Vaskova et al.
PloS one, 9(2), e88256-e88256 (2014-02-08)
In rodent female mammals, there are two forms of X-inactivation - imprinted and random which take place in extraembryonic and embryonic tissues, respectively. The inactive X-chromosome during random X-inactivation was shown to contain two types of facultative heterochromatin that alternate...
Eryn Wicklow et al.
PLoS genetics, 10(10), e1004618-e1004618 (2014-10-24)
Pluripotent epiblast (EPI) cells, present in the inner cell mass (ICM) of the mouse blastocyst, are progenitors of both embryonic stem (ES) cells and the fetus. Discovering how pluripotency genes regulate cell fate decisions in the blastocyst provides a valuable...
Increased FGF3 and FGF4 gene dosage is a risk factor for craniosynostosis.
Grillo L, et al.
Gene, 534, 435-435 (2014)
In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells.
Chien CC, et al.
Stem Cells, 24, 1759-1759 (2006)
Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity.
Yasuda K, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology, 94, 1355-1355 (2014)
Isolation and characterization of epithelial progenitor cells from human fetal liver.
Liu YN, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology, 38, 103-103 (2008)
FGF4 and retinoic acid direct differentiation of hESCs into PDX1-expressing foregut endoderm in a time- and concentration-dependent manner.
Johannesson M, et al.
PLoS ONE, 4, e4794-e4794 (2009)

Redes sociales

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

Investigación. Desarrollo. Producción.

Somos un proveedor líder para la industria de Ciencias de la Vida con soluciones y servicios para investigación, desarrollo y producción biotecnológicos, y para desarrollo y producción de tratamientos farmacéuticos

© 2021 Merck KGaA, Darmstadt, Alemania y/o sus filiales. Todos los derechos reservados.

Queda estrictamente prohibida la reproducción sin permiso de cualquiera de los materiales de la página web.